1042141-37-6

Basic information

• Product Name: Methyl 2-broMoiMidazo[1,2-a]pyridine-6-carboxylate
• Synonyms: Methyl 2-broMoiMidazo[1,2-a]pyridine-6-carboxylate;IMidazo[1,2-a]pyridine-6-carboxylic acid, 2-broMo-, Methyl ester
• CAS NO: 1042141-37-6
• Molecular Formula: C9H7BrN2O2
• Molecular Weight: 255.06808
• Product Categories: Heterocycle-Pyridine series
• Mol File: 1042141-37-6.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• Storage Temp.: Inert atmosphere,Room Temperature
• CAS DataBase Reference: Methyl 2-broMoiMidazo[1,2-a]pyridine-6-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 2-broMoiMidazo[1,2-a]pyridine-6-carboxylate(1042141-37-6)
• EPA Substance Registry System: Methyl 2-broMoiMidazo[1,2-a]pyridine-6-carboxylate(1042141-37-6)

Safety Data

• Hazardous Substances Data: 1042141-37-6(Hazardous Substances Data)

Usage

General Description

Methyl 2-bromoimidazo[1,2-a]pyridine-6-carboxylate, also known as the CAS number 158732-91-7, is a unique chemical compound that falls under the class of synthetic organic chemistry. This chemical is often referred to by its chemical formula, C11H8BrN3O2. As is often the case with complex organic chemicals, Methyl 2-bromimidazo[1,2-a]pyridine-6-carboxylate is generally used in research and development applications and its uses range from academics to pharmaceutical industries. However, the specifics regarding its usage or applications are not commonly available due to the highly specialized nature of the compound. It's crucial to handle it with care due to its reactive nature under certain physical and chemical conditions.

Upstream product

• 1042141-34-3 methyl 8-oxo-1,7-diazabicyclo[4.3.0]nona-2,4,6-triene-3-carboxylate hydrogenbromide 
• 1042141-35-4 BrH*C₁₁H₁₄N₂O₄ 

Relevant articles and documents

NOVEL HETEROARYL SUBSTITUTED IMIDAZO [1,2 -A] PYRIDINE DERIVATIVES

The present invention relates to novel heteroaryl substituted imidazopyridine derivatives, precursors thereof, and therapeutic uses of such compounds, having the structural formula (Ia) and to their pharmaceutically acceptable salt, compositions and methods of use. Furthermore, the invention relates to novel heteroaryl substituted imidazopyridine derivatives that are suitable for imaging amyloid deposits in living patients, their compositions, methods of use and processes to make such compounds. More specifically, the present invention relates to a method of imaging amyloid deposits in brain in vivo to allow antemortem diagnosis of Alzheimer's disease as well as measureing clinical efficacy of Alzheimer's disease therapeutic agents.